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Abstract
Early life stunting may have long-term effects on body composition, resulting in obesity-
related comorbidities. We tested the hypothesis that individuals stunted in early childhood
may be at higher cardiometabolic risk later in adulthood. 1753 men and 1781 women partici-
pating in the 1982 Pelotas (Brazil) birth cohort study had measurements of anthropometry,
body composition, lipids, glucose, blood pressure, and other cardiometabolic traits at age
30 years. Early stunting was defined as height-for-age Z-score at age 2 years below -2
against the World Health Organization growth standards. Linear regression models were
performed controlling for sex, maternal race/ethnicity, family income at birth, and birth-
weight. Analyses were stratified by sex when p-interaction<0.05. Stunted individuals were
shorter (β = -0.71 s.d.; 95% CI: -0.78 to -0.64), had lower BMI (β = -0.14 s.d.; 95%CI: -0.25
to -0.03), fat mass (β = -0.28 s.d.; 95%CI: -0.38 to -0.17), SAFT (β = -0.16 s.d.; 95%CI:
-0.26 to -0.06), systolic (β = -0.12 s.d.; 95%CI: -0.21 to -0.02) and diastolic blood pressure
(β = -0.11 s.d.; 95%CI: -0.22 to -0.01), and higher VFT/SAFT ratio (β = 0.15 s.d.; 95%CI:
0.06 to 0.24), in comparison with non-stunted individuals. In addition, early stunting was
associated with lower fat free mass in both men (β = -0.39 s.d.; 95%CI: -0.47 to -0.31) and
women (β = -0.37 s.d.; 95%CI: -0.46 to -0.29) after adjustment for potential confounders.
Our results suggest that early stunting has implications on attained height, body composition
and blood pressure. The apparent tendency of stunted individuals to accumulate less fat-
free mass and subcutaneous fat might predispose them towards increased metabolic risks
in later life.
Introduction
The prevalence of obesity is rapidly increasing worldwide, particularly affecting low and mid-
dle-income countries, where this condition co-exists with undernutrition.[1,2] Childhood
stunting is a significant global health issue, affecting 161 million children under 5 years of age
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in 2013.[3] It has a complex aetiology, involving household, environmental, socioeconomic
and cultural factors.[4] Research has suggested that stunting or poor height gain in early child-
hood may be a critical factor in promoting later obesity and obesity-related comorbidities.
[2,5,6]
Although the prevalence of stunting in the last decades has significantly decreased in mid-
dle income countries, it remains a global health priority due to its long-term consequences. In
Brazil, national data show a reduction in the prevalence of childhood stunting from 37% in
1974–1975 to 7% in 2006–2007 [7], and in the city of Pelotas, a city in Southern Brazil, from
13.9% in 1982 to 5% in 2004.[8]
A systematic review by The Maternal and Child Undernutrition Study Group [9], which
included cohort studies from five low- and middle-income countries (Brazil—The 1982 Pelo-
tas birth cohort, Guatemala, India, the Philippines, and South Africa) has shown that poor
growth early in life has longer-term consequences, such as shorter adult height, lower attained
schooling, reduced adult income, and decreased offspring birthweight.
Currently, findings on the association of early stunting with later adiposity are controver-
sial. In Guatemalan individuals, early stunting was associated with greater central adiposity
after adjustment for overall fatness and potential confounders; however, studies in adults from
New Delhi and Jamaican young adults failed to find evidence of an association between previ-
ous stunting and total or central adiposity. In addition, children who were undernourished in
the first 2 years of life and gained weight rapidly later in childhood and adolescence were at a
greater risk of obesity-related disease as they presented an unfavourable metabolic profile,
including increased glucose concentrations, higher blood pressure and harmful lipid profiles.
Evidence from the prospective British 1946 Birth Cohort Study indicated a substantial effect
of stunting in mid-childhood on higher mortality 30 to 60 years later.[10] The effects of stunt-
ing seemed also to influence the next generation, as women who were themselves stunted in
childhood had a tendency to have stunted offspring.[11] Furthermore, early stunting seemed
to be related to lower intelligence quotient, achieved schooling and income at 30 years of age.
[12]
Previous analyses from the 1982 Pelotas (Brazil) birth cohort, however, failed to find evi-
dence of associations of early stunting with metabolic syndrome components in young adults
(mean age 22.8 years).[13] These inconsistencies may be partly explained by the different
methods used to assess body composition. Most of these epidemiological studies relied on esti-
mates of body fat and fat distribution from standard anthropometry.
Using data from the same cohort at age 30 years, we previously showed that men and
women with early life stunting had lower subcutaneous abdominal fat thickness (SAFT), mea-
sured by the imaging technique ultrasound, but not visceral fat thickness (VFT) than other
individuals.[14] In the present study, we now expanded on those analyses, focusing on the
associations of early stunting with a wider range and more robust measurements of cardiome-
tabolic traits in adulthood. We hypothesised that adults who were stunted in early childhood
would have an unfavourable body composition and worse metabolic profile than those who
did not experience stunting in early life.
Materials and methods
Study design and population
Details of the 1982 Pelotas Birth Cohort Study have been previously published elsewhere. [15–
17] Briefly, it recruited 5914 live births in 1982 to mothers living in the urban part of Pelotas, a
Southern Brazil city. The study participants have been followed up and examined at different
times/phases. The most recent follow up was carried out in 2012–2013, which included a total
Stunting and cardiovascular risk factors
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of 3711 cohort members representing 68.1% of the original sample, including 325 members
known to have died. In the current analysis, we included 3534 individuals, 1753 men and 1781
women, who had complete information on early stunting and selected cardiometabolic traits
at age 30 years.[18]
In the early phases, verbal informed consent was obtained from the mothers, while in recent
phases; written consent was obtained from each participant. The study was approved by the
Ethical Committee of the Federal University of Pelotas and performed in accordance with the
Declaration of Helsinki. The exclusion criteria for the ultrasound examination in the 2012–13
phase of the Pelotas study included pregnancy or probable pregnancy, as well as have given
birth in the three months prior to the examination.
Study measurements
Anthropometry and body composition. Measurements were performed by trained staff
following standard protocols. Adults’ weight was recorded to the nearest 0.1 kg using cali-
brated electronic scales (TANITA BC-418 MA; Tanita, Tokyo, Japan). Supine length and
height was measured to the nearest 0.1cm in 1984 and 2013, respectively, using boards manu-
factured locally according to international specifications (AHRTAG; Healthlink Worldwide,
London, UK). Adults’ height was measured to the nearest 0.1cm using a wall-mounted stadi-
ometer (SECA 240; Seca, Birmingham, UK). Early stunting was defined as height-for-age Z-
score below -2 at age 2 years using the World Health Organization (WHO) criteria [19]. Body
mass index (BMI; in kg/m2) was calculated as weight divided by square height.Fat mass (kg)
fat free mass (kg) were derived using the air-displacement plethysmography (Bod Pod1,
Cosmed, Concord, CA USA). Body density was firstly calculated as mass/body volume and
body fat percentage was estimated using the Siri equation.[20]
A Toshiba Xario (Toshiba Medical Systems Corporation, Tochigi-ken, Japan) ultrasound
machine with a 3.5-MHz convex transducer was used to derive visceral and subcutaneous
(total, deep and superficial) abdominal fat thicknesses. VFT was estimated by the distance
between the peritoneum and the lumbar spine and SAFT was defined as the distance between
the posterior line of dermis to the linea alba. Both measurements were obtained at the intersec-
tion between the xyphoid line and the waist circumference. The relative intra-observer techni-
cal error of measurement for the visceral thickness was 4.1% and 3.4% for subcutaneous fat
thickness, whereas the relative inter-observer technical error of measurement was 3.1% for
both measurements.
Biochemistry and clinical measurements. Non-fasting blood samples were collected by
venous puncture. Whole blood samples were spotted onto filter paper (Whatman 903; Maid-
stone, UK), air-dried, and stored in sealed envelopes at ambient temperature. Random glucose
was measured by an automatic enzymatic colorimetric method. Glycated haemoglobin
(HbA1c) was measured by the Variant (Bio-Rad, Hercules, CA) ion-exchange high-perfor-
mance liquid chromatography (HPLC) method. High sensitive C reactive protein was analysed
using immune-turbidimetry test with intra-inter assay coefficient of variation of 4.2%.
Blood lipids (total cholesterol, high and low-density lipoprotein and triglycerides) were
measured by standard enzymatic methods. All the above analyses were run in an automated
Mindray BS 380 Chemistry Analyser (Shenzhen Mindray Bio-Medical Electronics Co., Ltd,
China).
Carotid intima-media thickness (CIMT) was measured with a Toshiba Xario (Toshiba
Medical Systems Corp) ultrasound machine with a 3.5-MHz linear transducer. CIMT was
measured at the posterior wall of the right and left common carotid arteries in longitudinal
planes, through an image of a 10-mm long section proximal to the carotid bulb. The image
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were analysed using the Carotid Analyser for Research (Medical Imaging Applications,
MIA-LLC), which automatically calculated the mean value of 90 measurements (frames) taken
[21].
Arterial blood pressure was measured twice (at the beginning and end of the examination)
with an automated blood pressure monitor (Omron HEM-705CPINT) with the participant
rested and seated for at least five minutes.
Other covariates. Information on a priori potential confounders was collected. Family
income in 1982 was calculated as the sum of the monthly incomes of all working persons living
in the household, expressed in multiples of the minimum wage (1/1.1-3/3.1–6;>6). Maternal
self-reported skin colour was collected as a marker of race/ethnicity and categorized into two
groups (white/non-white). Birthweight was measured to the nearest 10g using calibrated pae-
diatric scales (Filizola, São Paulo, Brazil) by trained anthropometrists following standard
protocols.
Statistical analysis
Statistical analyses were performed with Stata (version 13; StataCorp, College Station, TX).
Descriptive data are presented as mean ± standard deviation (s.d.) or median and interquartile
range. Inter-correlations between the independent variables were assessed by Spearman’s cor-
relation. All outcomes were log-transformed to achieve normal distributions, and were poste-
riorly standardized to allow direct comparisons of the regression coefficients. Therefore, the
Beta (β) coefficients indicate the standardised difference in the outcomes comparing stunted
versus non-stunted individuals.
Inter-correlations between the independent variables were assessed by Spearman’s correla-
tion. Co-linearity between parameters was indicated by a variance inflation factor (VIF) > 5.
Linear regression models were derived to analyse the relationship between stunting at age 2
years (exposure) and the various body composition and the metabolic traits variables (out-
comes). We initially tested whether sex modified the association of stunting at age 2 years with
each outcome at age 30 years, and presented the analyses stratified by sex when p-inter-
action<0.05. For each outcome, we ran crude models (including only the outcome and stunt-
ing at age 2 years), as well as models adjusted for potential confounders measured at birth (sex,
maternal race/ethnicity, family income at birth, and birthweight). We also assessed the associa-
tion between stunting at age 2 years and VFT adjusting for potential confounders and current
BMI, for comparative purposes. Additional inverse-probability weighted models were applied,
which account for possible selection bias in cohort follow-up.
We applied inverse-probability weighting (IPW) [22] to take into account selection bias by
using the teffects ipw command in Stata. For comparative purposes, IPW models were
adjusted separately for each outcome, including the same potential confounders used in the
linear regression models. The 95% confidence intervals (CI) were estimated using the jackknife
method. A 5% significance level was applied.
Results
Characteristics of the study population are summarised in Table 1. The mean age of the partic-
ipants was 30.20years (s.d. = 0.34). Men had greater length at 2 years, attained height at 30
years of age, weight, BMI, fat-free mass, VFT, systolic and diastolic blood pressure, random
glucose level, total and low-density lipoprotein (LDL), and triglycerides, but lower fat mass,
subcutaneous abdominal fat, C-reactive protein, and high-density lipoproteins (HDL) than
women at age 30 years.
Stunting and cardiovascular risk factors
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Stunting at age 2 years was more prevalent in men than in women (16.3% and 11.6%,
respectively). It was higher, almost double, amongst black individuals than whites, and it was
much higher, six to ten times more, among those in the poorest families relative to those in the
highest income category (Table 2).
The correlations between the independent variables are shown in Table 3.
Associations of stunting at age 2 years with cardiometabolic traits at age 30 years are shown
in Table 4. In the crude models, stunting at 2 years was associated with lower adult height, cur-
rent BMI, fat-mass, and total SAFT, and with higher VFT, VFT/SAFT ratio and random glu-
cose concentration. After adjustment for potential confounders, stunted individuals were
shorter (β = -0.71 s.d.; p<0.001); had lower BMI (β = -0.14 s.d.; p = 0.01), fat mass (β = -0.28 s.
d.; p<0.001), SAFT (β = -0.16 s.d.; p = 0.002), systolic blood pressure (β = -0.12 s.d.; p = 0.01),
and diastolic blood pressure (β = -0.11 s.d.; p = 0.04); and higher VFT/SAFT ratio (β = 0.15 s.
d.; p = 0.001), in comparison with non-stunted individuals. Higher visceral fat thickness
(β = 0.08 s.d.; p = 0.04) in stunted individuals at 2 years only appeared after adjustment for cur-
rent BMI.
Table 5 presents sex-specific analyses performed for those outcomes in which sex modifica-
tion was identified (p-interaction<0.05). After adjustment for potential confounders, early
stunting was associated with lower fat free mass in both men (β = -0.39 s.d.; p<0.001) and
women (β = -0.37 s.d.; p<0.001). Additional inverse-probability weighted models showed
essentially similar associations (S1 and S2 Tables).
Table 1. Characteristics of the study sample.
Traits Men Women p-value§
n = 1772 n = 1853
Length at 2 years (cm) -0.74 (-1.62) -0.58 (1.54) <0.0001
Height (cm) at 30 years 174.50 (8.80) 161.30 (8.30) <0.0001
Weight (kg) at 30 years 80.20 (20.20) 65.90 (20.00) 0.0001
BMI (kg/m2) at 30 years 26.33 (5.82) 25.32 (7.19) <0.0001
Fat mass (kg) at 30 years 19.77 (14.28) 24.57 (15.06) 0.0001
Fat mass (%) at 30 years 25.10 (12.90) 37.30 (12.00) <0.0001
Fat-free (kg) at 30 years 60.51 (10.18) 41.82 (6.95) <0.0001
VFT (cm) at 30 years 6.64 (2.57) 4.63 (1.98) <0.0001
Total SAFT (cm) at 30 years 1.76 (1.29) 2.42 (1.60) <0.0001
Ratio VFT/SAFT 4.61±3.15 2.31±1.39 <0.0001
Mean carotid intima media thickness (cm) 0.59±0.02 0.58±0.02 <0.0001
Systolic blood pressure (mmHg) at 30 years 127.00 (16.00) 113.50 (14.50) 0.0001
Diastolic blood pressure (mmHg) at 30 years 76.50 (12.50) 73.00 (11.00) 0.0001
Glycated haemoglobin (HbA1c) at 30 years 5.10 (0.40) 5.10 (0.40) 0.01
C-reactive protein (mg/L) at 30 years 2.79±4.36 5.05±6.16 <0.0001
Random glucose (mg/dL) at 30 years 92.52±30.30 86.65±20.50 <0.0001
Total cholesterol (mg/dL) at 30 years 189.00 (51.00) 186.00 (48.00) 0.02
HDL cholesterol (mg/dL) at 30 years 52.00 (16.00) 63.00 (19.00) <0.0001
LDL cholesterol (mg/dL) at 30 years 110.00 (40.00) 103.00 (36.00) 0.0001
Triglycerides (mg/dL) at 30 years 140.53±129.12 102.42±61.25 <0.0001
Data are means ± s.d. or median (interquartile range).
§ Mann-Whitney-Wilcoxon test
VFT—visceral fat by ultrasound; SAFT—subcutaneous abdominal fat by ultrasound;
HbA1c shown as percentage of total haemoglobin
https://doi.org/10.1371/journal.pone.0192196.t001
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Discussion
Our results from this large, long-running, middle-income country birth cohort study suggest
that stunting at age 2 years has implications on attained height, body composition and blood
pressure. Consistently with the current literature, we observed that men and women with early
stunting were shorter as adults than non-stunted individuals.
Central obesity has been reported to be greater in stunted individuals who were undernour-
ished in childhood, born in Jamaica in the 1970, and in 1986.[23–25] However, most of these
studies relied on anthropometric indicators of body fat, such as waist and hip circumferences
and skinfold thickness, rather than directly assessed specific fat compartments, such as visceral
and subcutaneous fat, given that the distribution of these fat compartments may have different
metabolic consequences. Visceral fat has been associated with a low-grade inflammation due
to the increased secretion of numerous pro-inflammatory cytokines, which may play an
important role in many diseases, promoting angiogenesis, inflammation, cell proliferation,
and insulin resistance.[26–28] Although some studies have shown that subcutaneous fat may
have an independent antiatherogenic effect, others have suggested that it might be a significant
predictor of adverse metabolic consequences in some populations.[29,30] In our study, we
found an association between early stunting and higher visceral fat accumulation in adulthood
only after adjustments for current BMI. In addition, our findings also suggest that early stunt-
ing may decrease lean mass, subcutaneous abdominal fat accumulation, as well as total body
fat mass.
Childhood stunting may lead to less lean mass as individuals who are undernourished tend
to use up protein stores in the muscle as a source of energy as a consequence of inadequate
energy intake[31]. Muscle tissue catabolism is significantly greater during protein–energy mal-
nutrition and results in the reduction in the muscle mass in those individuals [32]. The loss of
subcutaneous fat may also be a result of insufficient food intake that is deficient of calories and
protein. Reduction in subcutaneous fat is often seen in children with marasmus [33,34]. An
important characteristic of marasmus is growth failure, which results in those children not
reaching their full potential height (stunted). While, children with kwashiorkor retain subcuta-
neous fat as calorie intake is adequate but are protein deficient [33,34].
This body composition profile resulting from stunting might be harmful in relation to met-
abolic disorders. Lean mass is the largest insulin-sensitive tissue in the body and plays a pivotal
role in the maintenance of glucose metabolism.[35,36] Loss or reduced lean mass may there-
fore play a fundamental role in altering glucose homeostasis including metabolic dysregulation
of insulin stimulated glucose uptake and may contribute to the development of metabolic
Table 2. Stunting at age 2 years by covariates.
Variables Men Women
n % of stunting at 2 years 95% CI p-value n % of stunting at 2 years 95% CI p-value
Overall 3,037 16.3 14.9 17.8 - 2,876 11.6 10.4 12.9 -
Maternal race/ethnicity <0.001 <0.001
White 2,479 14.6 13.1 16.2 2,371 9.5 8.3 10.8
Non-white 556 23.7 20.0 27.8 504 21.8 18.1 26.0
Family income at birth (in minimum wages) <0.001 <0.001
< = 1 666 29.9 26.1 34.1 622 24.6 21.0 28.7
1.1–3 1,463 16.7 14.7 18.9 1,325 10.8 9.2 12.8
3.1–6 544 7.5 5.5 10.2 547 5.8 4.0 8.4
>6 351 5.2 3.2 8.5 366 2.4 1.1 4.9
https://doi.org/10.1371/journal.pone.0192196.t002
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disorders later in life.[37] Low lean mass has also been found to be the strongest risk factors
for metabolic syndrome in adults, independent of abdominal fat.[38] The mechanisms con-
tributing to reduced insulin stimulated glucose uptake, impaired insulin signalling and action
on lean mass are not fully understood. Increased accumulation of adipose tissue and intramus-
cular fat, dysregulated production of inflammatory adipokines, increased renin-angiotensin-
aldosterone system activity, and decreased mitochondrial oxidative phosphorylation flux in
the muscle have been suggested to play a significant role in the development of insulin resis-
tance in lean mass.[37]
Table 5. Associations of stunting at age 2 years with glycated haemglobin, total cholesterol and HDL cholesterol,
and fat free mass at age 30 years by sex.
Traits (s.d. ln) Crude Adjusted
N Beta 95%CI p-value N Beta 95%CI p-value
Males
Fat free mass 1587 -0.50 -0.58 -0.42 <0.001 1583 -0.39 -0.47 -0.31 <0.001
Glycated haemoglobin 1591 0.12 -0.02 0.26 0.09 1587 0.09 -0.06 0.23 0.26
Total cholesterol 1590 0.04 -0.10 0.19 0.56 1586 0.04 -0.11 0.20 0.57
HDL cholesterol 1590 0.14 0.01 0.27 0.04 1586 0.12 -0.02 0.26 0.08
Females
Fat free mass 1644 -0.41 -0.50 -0.32 <0.001 1634 -0.37 -0.46 -0.29 <0.001
Glycated haemoglobin 1652 -0.13 -0.28 0.03 0.11 1642 -0.15 -0.31 0.01 0.07
Total cholesterol 1652 -0.19 -0.34 -0.04 0.01 1642 -0.16 -0.31 0.00 0.05
HDL cholesterol 1652 -0.24 -0.38 -0.09 0.001 1642 -0.13 -0.27 0.02 0.09
Adjusted for family income at birth, maternal race/ethnicity, and birthweight.
Bold values signifies p<0.05.
https://doi.org/10.1371/journal.pone.0192196.t005
Table 4. Associations of stunting at age 2 years with cardiometabolic traits at age 30 years.
Traits (s.d. ln) Crude Adjusted
N Beta 95%CI p-value N Beta 95%CI p-value
Height 3309 -0.72 -0.82 -0.62 <0.001 3294 -0.71 -0.78 -0.64 <0.001
BMI 3256 -0.17 -0.28 -0.07 0.001 3242 -0.14 -0.25 -0.03 0.01
Fat mass 3231 -0.40 -0.50 -0.30 <0.001 3217 -0.28 -0.38 -0.17 <0.001
VFT 3203 0.11 0.00 0.21 0.04 3189 0.00 -0.09 0.09 0.99
Total SAFT 3221 -0.25 -0.35 -0.15 <0.001 3207 -0.16 -0.26 -0.06 0.002
VFT/SAFT ratio 3203 0.28 0.18 0.39 <0.001 3189 0.15 0.06 0.24 0.001
Mean CMIT 2922 -0.02 -0.13 0.08 0.65 2909 -0.06 -0.18 0.05 0.27
Systolic blood pressure 3319 0.01 -0.09 0.12 0.80 3304 -0.12 -0.21 -0.02 0.01
Diastolic blood pressure 3319 -0.04 -0.14 0.06 0.45 3304 -0.11 -0.22 -0.01 0.04
C-reactive protein 3242 -0.06 -0.17 0.04 0.22 3228 0.00 -0.11 0.10 0.98
Random glucose 3242 0.12 0.02 0.23 0.02 3228 0.08 -0.03 0.19 0.15
LDL cholesterol 3242 -0.03 -0.13 0.07 0.55 3228 -0.06 -0.17 0.05 0.27
Triglycerides 3242 -0.07 -0.18 0.03 0.16 3228 -0.08 -0.19 0.02 0.11
Adjusted for sex, family income at birth, maternal race/ethnicity, and birthweight.
BMI—body mass index; VFT—visceral fat thickness; SAFT—subcutaneous abdominal fat thickness; CMIT—carotid
intima-media thickness.
Bold values signifies p<0.05.
https://doi.org/10.1371/journal.pone.0192196.t004
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In addition, reduced subcutaneous fat may contribute to fat accumulation in other tissues
and organs. Failure of fat cell formation in the subcutaneous fat compartment as body fat
increases, might lead to storage of fat in tissues such as visceral adipose tissue, pancreas, muscle
and liver.[39] This excess storage might contribute to the unfavourable distribution of abdomi-
nal fat and hepatic steatosis, as well as impaired insulin action resulting in insulin resistance,
glucose intolerance and diabetes.[40]
Our results on cardiovascular and metabolic traits were not consistent across sex. Men who
were stunted had higher HDL cholesterol levels, while stunted women had lower total choles-
terol than the non-stunted ones. Previous analyses from the 1982 Pelotas (Brazil) birth cohort
assessing associations with early stunting, defined using the 2006 WHO Child Growth Stan-
dards for height-for-age z score, showed mixed results, Nazmi et al. [41] found that men who
were stunted at age 2 years and had abdominal obesity at age 23y had higher C-reactive protein
levels, suggesting an increased risk for chronic diseases. Grillo et al. [13], studying metabolic
syndrome components at adulthood (mean age 22.8 years), found that men and women who
were stunted at age 2 years had lower triglycerides and women had lower HDL-cholesterol lev-
els; however, these associations disappeared after adjustment for confounding variables. Buf-
farini et al.[42], using data from the 1982 and 1993 Pelotas (Brazil) birth cohorts, reported that
those individuals who were stunted at age 1 had lower glycated haemoglobin in adolescents
aged 18y, but not in adults aged 30 years. These discrepancies may be partly explained by
excluding potential confounders like birth weight and or including mediating variables such as
attained height and BMI to the analysis. These adjustments might potentially introduce bias
because of inappropriate controlling.
We acknowledge some limitations of our study. Lipids and glucose levels were measured
from non-fasting blood samples is our study; while HDL cholesterol is independent of fasting
time [43], triglycerides are influenced by time of the day and fasting time.[44] However, new
evidence suggests that the impact of fasting on lipids is modest [45]. We relied on ultrasound
measurements of VFT and SAFT as proxies for these abdominal fat compartments. This tech-
nique has been found to correlate strongly with magnetic resonance imaging estimates of
abdominal fat compartments in a variety of settings and populations using the same protocol,
which was rigorously quality controlled.[46–48] We cannot rule out residual confounding, as
we cannot exclude unmeasured genetic and environmental factors that may contribute to
those associations.
To our knowledge, this is one of the largest reported samples with abdominal ultrasound
measurements, and by far the largest from a low- or middle-income setting, which addressed
the associations of early stunting with several cardiometabolic traits in adulthood. The pro-
spective design of our study made it less susceptible to recall bias, as potential confounding
variables were measured soon after delivery, and the higher follow-up rate of 68.1% at age 30
years is likely to reduce the chance of selection bias. The use of objective measurements/indica-
tors of body composition is also a strength of this analysis.
In conclusion, our findings indicate that adults who had early childhood stunting may tend
to accumulate less lean mass and subcutaneous fat, and may have a tendency to have a profile
with higher visceral fat. This body composition profile, characterized by a preference to accu-
mulate visceral fat rather than subcutaneous fat, might be deleterious to their future metabolic
health. The current and previous reported findings derived from this cohort do not yet show
evidence for increased biochemical markers of metabolic disease later into early adulthood,
possibly because the cohort is still young to present marked alterations in the evaluated traits.
Our findings of a worse adiposity profile associated with stunting in early childhood do not
preclude, however, that further developments into negative cardiometabolic profiles may
occur, thus warranting longer-term evaluations.
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